CenterWatch

Head and Neck Cancer Clinical Trials

A listing of Head and Neck Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Arizona

View More ▼

Scottsdale Arizona

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Arkansas

Fayetteville Arkansas 72703

A Phase 2 clinical study for patients with Head and Neck Neoplasms

California

Mirati Research Site
San Diego California 92093

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More ▼

Los Angeles California 90033

A clinical study for patients with Cystic Fibrosis

Los Angeles California 90095

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles California 90025

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

San Francisco California 94115

A Phase 2 clinical study for patients with Locally Advanced Basal Cell Carcinoma, Skin Cancer or Cutaneous Malignancy

Stanford California 94305

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Connecticut

New Haven Connecticut 06520

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

District of Columbia

Washington District of Columbia 20007

A clinical research study of Nilotinib + Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Florida

Tampa Florida 33612

A clinical trial to evaluate treatments using MGA271 for patients

Tampa Florida 33612-9497

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Georgia

Memorial University Medical Center
Savannah Georgia 31404

ECOG E1305: A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer.

Memorial University Medical Center
Savannah Georgia 31404

RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer.

Memorial University Medical Center
Savannah Georgia 31404

RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

Memorial University Medical Center
Savannah Georgia 31404

RTOG 1216: Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

Illinois

View More ▼

Chicago Illinois 60637

A clinical research study of Everolimus escalating dose and Everolimus or Placebo for the treatment of Head and Neck Cancer

Chicago Illinois 60637

A clinical trial to evaluate treatments using MGA271 for patients

Chicago Illinois 60637

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Iowa

Iowa City Iowa 52242

A clinical trial seeking patients for a research study for the treatment of Head and Neck Neoplasms

Kansas

Fairway Kansas 66205

Patients are needed to participate in a clinical research study of Cetuximab, Carboplatin and 5 - Fluorouracil to evaluate Head and Neck Neoplasms

Maryland

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study evaluating Reirradiation and MK-3475 for the treatment of Recurrent Head and Neck Cancer or Carcinoma, Squamous Cell of Head and Neck

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Baltimore Maryland 21231

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Massachusetts

Mirati Research Site
Boston Massachusetts 02114

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Mirati Research Site
Boston Massachusetts 02115

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More ▼

Boston Massachusetts 02114

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Boston Massachusetts 02114

A clinical trial to evaluate treatments using MGA271 for patients

Boston Massachusetts 02215

A clinical trial to evaluate treatments using MGA271 for patients

Boston Massachusetts 02114

A Phase 1/1b clinical study for patients with Advanced Cancer

Boston Massachusetts 02215

A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating Urelumab and Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Michigan

Minnesota

Minneapolis Minnesota 55455

A clinical study for patients with Cystic Fibrosis

Mississippi

Missouri

Mirati Research Site
St. Louis Missouri 63110

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Mirati Research Site
St. Louis Missouri 63110

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

View More ▼

St. Louis Missouri 63110

A clinical research study of nab-paclitaxel, Cisplatin, Carboplatin and Cetuximab for the treatment of Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma or Cancer of the Head and Neck

St. Louis Missouri 63110

A Phase 1/1b clinical study for patients with Advanced Cancer

St. Louis Missouri 63110

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Nevada

Las Vegas Nevada 89169

Patients are needed to participate in a clinical research study of MPDL3280A to evaluate Solid Cancers

Reno Nevada 89502

A Phase 2 clinical study for patients with Head and Neck Neoplasms

New Jersey

New York

Biomedical Research Alliance of New York
Bronx New York 10461

Head and Neck Cancer, Melanoma, and Other Superficial Cancers

Mirati Research Site
New York New York 10032

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies